Saluda Medical Pty Limited

Jun 09, 2020

Saluda Medical Appoints Jim Schuermann as President and Robert Gaffney as Chief Operating Officer

Jan 21, 2020

Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting

Dec 20, 2019

Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

Sep 16, 2019

Saluda Medical Announces European Commercial Launch of Evoke®, the First and Only ECAP-Controlled, Closed-Loop SCS System for Chronic Pain Relief

Jun 28, 2019

Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group

Jun 27, 2019

Saluda Medical Secures Debt Financing From Medtronic

Jun 03, 2019

Saluda Medical Announces Clinical Study Results for Evoke® ECAP-Controlled, Closed-Loop SCS System for the Treatment of Chronic Pain

May 20, 2019

Saluda Medical Announces New 3-Month, 12-Month and 18-Month Data Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System to be Presented at 14th INS World Congress

May 30, 2017

Saluda Medical Secures AU$53 Million in Series D Financing